Fas aggregation does not correlate with Fas-mediated apoptosis

Journal of Immunology

Volumn 167, Issue 1, 2001, Pages 82-89

  Lee, Y J ^a   Shacter, E ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; FAS ANTIGEN; PROTEIN KINASE C INHIBITOR; TOSYLLYSYL CHLOROMETHYL KETONE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0035399925     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.1.82     Document Type: Article

References (48)

1. Tumor necrosis factor receptor and Fas signaling mechanisms
2. The Fas death factor
3. CD95's deadly mission in the immune system
4. Fas ligand mediates activation-induced cell death in human T lymphocytes
5. Autocrine T cell suicide mediated by APO-1/(Fas/CD95)
6. Fas(CD95)/FasL interaction required for programmed cell death after T-cell activation
7. Fas-dependent and Fas-independent mechanisms for selection of mature human B cell repertoire
8. Regulation of germinal center B cell differentiation: Role of the human APO-1/Fas (CD95) molecule
9. Differentiation and apoptosis of human germinal center B-lymphocytes
10. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome
11. Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type 1a
12. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor
13. A novel protein that interacts with the death domain of Fas/APO-1 contains a sequence motif related to the death domain
14. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis
15. A novel protein domain required for apoptosis: Mutational analysis of human Fas antigen
16. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex
17. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death
18. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC)
19. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals
20. High expression of APO-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children
21. Expression of the APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype
22. Defective expression of hematopoietic cell protein tyrosine phosphatase (HCP) in lymphoid cells blocks Fas-mediated apoptosis
23. Distinct molecular mechanisms of Fas resistance in murine B lymphoma cells
24. Bax is frequently compromised in Burkitt's lymphomas with irreversible resistance to Fas-induce apoptosis
25. Activation of protein kinase C attenuates early signals in Fas-mediated apoptosis
26. Protein kinase C. inhibits CD95 (Fas/APO-1)-mediated apoptosis by at least two different mechanisms in Jurkat T cells
27. Inhibition of the protein kinase C pathway promotes anti-CD95-induced apoptosis in Jurkat cells
28. Activation of protein kinase C prevents induction of apoptosis by geranylgeraniol in human leukemia HL60 cells
29. Expression and function of CD95 (FAS/APO-1) in leukaemia-lymphoma tumour lines
30. Death receptors: Signaling and modulation
31. Activation-induced aggregation and processing of the human Fas antigen
32. Self-association of the "death domains" of the pb tumor necrosis factor (TNF) receptor and Fas/Apo prompts signaling for TNF and Fas/Apoi effects
33. Bel-2 does not protect Burkitt's lymphoma cells from oxidant-induced cell death
34. Oxidative stress inhibits apoptosis in human lymphoma cells
35. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
36. Cellular events in Fas/APO-1-mediated apoptosis in JURKAT T lymphocytes
37. Molecular ordering of the cell death pathway
38. Common regulation of apoptosis signaling induced by CD95 and the DNA-damaging stimuli etoposide and γ-radiation downstream from caspase-8 activation
39. Chemotherapeutic drug-induced apoptosis in human leukaemic cells is independent of the Fas (APO-1/CD95) receptor/ligand system
40. Comparison of apoptosis in wild-type and Fas-resistant cells: Chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interaction
41. Two CD95 (APO-1/Fas) signaling pathways
42. The role of c-FLIP in modulation of CD95-induced apoptosis
43. A conserved family of cellular genes related to the baculovirus IAP gene and encoding apoptosis inhibitors
44. X-linked IAP is a direct inhibitor of cell death proteases
45. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases
46. Crystal structure of the soluble human 55 kD TNF receptor-human TNFβ complex: Implication for TNF receptor activation
47. NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain
48. N-α-tosyl-L-lysine chloromethyl ketone and N-α-tosyl-L-phenylalanine chloromethyl ketone inhibit protein kinase C